INSMED INC Sale of Stock, Price Per Share
INSMED INC (INSM) had Sale of Stock, Price Per Share of $96.00 per share as of 2025-06-30, per its 10-K filed 2026-02-19.
Financial Statements › Notes
us-gaap:SaleOfStockPricePerShare · last filed 2026-02-19
- 2025-06-30: Sale of Stock, Price Per Share $96.00.
- 2024-05-31: Sale of Stock, Price Per Share $51.50.
- 2022-12-31: Sale of Stock, Price Per Share $20.00.
- 2022-10-31: Sale of Stock, Price Per Share $20.00.
| Period end | Sale of Stock, Price Per Share |
|---|---|
| 2025-06-30 | $96.00 10-K · filed 2026-02-19 |
| 2024-05-31 | $51.50 10-K · filed 2026-02-19 |
| 2022-12-31 | $20.00 10-K · filed 2025-02-20 |
| 2022-10-31 | $20.00 10-Q · filed 2024-10-31 |
| 2022-10-19 | $20.00 10-K · filed 2023-02-23 |
| 2021-06-30 | $25.00 10-K · filed 2024-02-22 |
| 2020-06-30 | $23.25 10-K · filed 2023-02-23 |
| 2019-06-30 | $26.00 10-K · filed 2022-02-17 |
| 2019-05-24 | $26.00 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |